T1	Eq-Comparison 33 42	scheduled
E1	Eq-Comparison:T1 Temporal-Period:T38
T2	Procedure 47 67	total pancreatectomy
E2	Procedure:T2 Name:T39 Temporality:E1
T3	Or 68 70	or
E3	Or:T3 Arg:E2 Arg2:E4
T4	Procedure 71 94	pancreaticoduodenectomy
E4	Procedure:T4 Name:T68 Temporality:E1
T5	Temporal-Connection 124 132	prior to
E5	Temporal-Connection:T5 
A1	Temporal-Connection-Type-Value E5 before
T6	Study 137 142	study
E6	Study:T6 Study-Of:E7
T7	Procedure 151 160	procedure
E7	Procedure:T7 
T8	Condition 192 205	liver disease
E8	Condition:T8 Name:T40
T9	Temporal-Connection 206 212	before
E9	Temporal-Connection:T9 Arg:E8 Arg2:E10
A2	Temporal-Connection-Type-Value E9 before
T10	Procedure 213 233	total pancreatectomy
E10	Procedure:T10 Name:T41
T11	Or 234 236	or
E11	Or:T11 Arg:E10 Arg2:E12
T12	Procedure 237 260	pancreaticoduodenectomy
E12	Procedure:T12 Name:T42
T13	Exception 262 271	excluding
E13	Exception:T13 Except:E14 From:E8
T14	Condition 272 277	NAFLD
E14	Condition:T14 Name:T69
T15	Condition 291 308	co-morbid disease
E15	Condition:T15 Name:T44 Severity:T43
T16	Indication 327 337	indication
E16	Indication:T16 Indication-For:E17
T17	Procedure 346 362	pancreas surgery
E17	Procedure:T17 Name:T45
T18	Condition 369 378	Pregnancy
E18	Condition:T18 Name:T46
T19	Condition 388 397	condition
E19	Condition:T19 
T20	Assertion 426 431	would
E20	Assertion:T20 Asserted:T47
A3	Assertion-Type-Value E20 hypothetical
T21	Study 465 470	trial
E21	Study:T21 Stability:T47
T22	Procedure 551 563	liver biopsy
E22	Procedure:T22 Name:T48
T23	Temporal-Connection 600 606	before
E23	Temporal-Connection:T23 Arg:E41 Arg2:E24
A4	Temporal-Connection-Type-Value E23 before
T24	Eq-Comparison 607 611	last
E24	Eq-Comparison:T24 Temporal-Recency:T74
T25	Encounter 612 617	visit
E25	Encounter:T25 Temporality:E24
T26	Observation 654 667	lipid content
E26	Observation:T26 Name:T49 Eq-Comparison:E27
T27	Eq-Comparison 668 671	<2%
E27	Eq-Comparison:T27 Operator:T50 Value:T51 Unit:T52
T28	Observation 677 688	Haemoglobin
E28	Observation:T28 Name:T53 Eq-Comparison:E29
T29	Eq-Comparison 689 698	<6 mmol/L
E29	Eq-Comparison:T29 Operator:T54 Value:T55 Unit:T56 Per:T57
T30	Observation 704 707	INR
E30	Observation:T30 Name:T58
T31	Eq-Comparison 708 712	>1.5
E31	Eq-Comparison:T31 Operator:T59 Value:T60
T32	Observation 718 729	Trombocytes
E32	Observation:T32 Name:T61 Eq-Comparison:E33
T33	Eq-Comparison 730 741	<40 × 109/L
E33	Eq-Comparison:T33 Operator:T62 Value:T63 Unit:T64 Value:T65 Per:T80
T34	Modifier 747 751	Skin
E34	Modifier:T34 Modifies:T66
T35	Condition 752 761	infection
E35	Condition:T35 Name:T66
T36	Procedure 776 782	biopsy
E36	Procedure:T36 Name:T67
T37	Assertion 783 790	will be
E37	Assertion:T37 Asserted:E36
A5	Assertion-Type-Value E37 hypothetical
T38	Eq-Temporal-Period 33 42	scheduled
A6	Eq-Temporal-Period-Value T38 future
T39	Procedure-Name 47 67	total pancreatectomy
T40	Condition-Name 192 205	liver disease
T41	Procedure-Name 213 233	total pancreatectomy
T42	Procedure-Name 237 260	pancreaticoduodenectomy
T43	Severity 284 290	Severe
A7	Severity-Value T43 severe
T44	Condition-Name 291 308	co-morbid disease
T45	Procedure-Name 346 362	pancreas surgery
T46	Condition-Name 369 378	Pregnancy
T47	Stability 432 441	interfere
A8	Stability-Value T47 change
T48	Procedure-Name 551 563	liver biopsy
T49	Observation-Name 654 667	lipid content
A9	Observation-Type-Value T49 lab
T50	Eq-Operator 668 669	<
A10	Eq-Operator-Value T50 LT
T51	Eq-Value 669 670	2
T52	Eq-Unit 670 671	%
T53	Observation-Name 677 688	Haemoglobin
A11	Observation-Type-Value T53 lab
T54	Eq-Operator 689 690	<
A12	Eq-Operator-Value T54 LT
T55	Eq-Value 690 691	6
T56	Eq-Unit 692 696	mmol
T57	Eq-Unit 697 698	L
T58	Observation-Name 704 707	INR
A13	Observation-Type-Value T58 lab
T59	Eq-Operator 708 709	>
A14	Eq-Operator-Value T59 GT
T60	Eq-Value 709 712	1.5
T61	Observation-Name 718 729	Trombocytes
A15	Observation-Type-Value T61 lab
T62	Eq-Operator 730 731	<
A16	Eq-Operator-Value T62 LT
T63	Eq-Value 731 733	40
T64	Eq-Unit 734 735	×
T65	Eq-Value 736 739	109
T66	Condition-Name 752 761	infection
T67	Procedure-Name 776 782	biopsy
T68	Procedure-Name 71 94	pancreaticoduodenectomy
T69	Condition-Name 272 277	NAFLD
T70	Exception 310 317	besides
E38	Exception:T70 From:E15 Except:E16
R1	Caused-By Arg1:T47 Arg2:E19	
T71	Condition 519 537	Metastatic disease
E39	Condition:T71 Name:T72
T72	Condition-Name 519 537	Metastatic disease
T73	Modifier 538 550	Percutaneous
E40	Modifier:T73 Modifies:T48
T74	Eq-Temporal-Recency 607 611	last
A17	Eq-Temporal-Recency-Value T74 most-recent-time
T75	Procedure 590 599	evaluated
E41	Procedure:T75 Name:T76
T76	Procedure-Name 590 599	evaluated
T77	Assertion 584 589	to be
E42	Assertion:T77 Asserted:E41
A18	Assertion-Type-Value E42 hypothetical
T78	Procedure 624 639	MR spectroscopy
E43	Procedure:T78 Name:T79
T79	Procedure-Name 624 639	MR spectroscopy
R2	Found-By Arg1:E26 Arg2:E43	
T80	Eq-Unit 740 741	L
T81	Modifier 765 769	area
E44	Modifier:T81 Modifies:T66 Modifies2:T67
